| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 5.12e-09 | 5 | 17 | 3 | GO:0030156 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine phosphatase activity | 9.21e-05 | 17 | 17 | 2 | GO:0005001 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein phosphatase activity | 9.21e-05 | 17 | 17 | 2 | GO:0019198 | |
| GeneOntologyMolecularFunction | small GTPase binding | 2.37e-03 | 321 | 17 | 3 | GO:0031267 | |
| GeneOntologyMolecularFunction | tRNA binding | 2.45e-03 | 87 | 17 | 2 | GO:0000049 | |
| GeneOntologyMolecularFunction | GTPase binding | 3.28e-03 | 360 | 17 | 3 | GO:0051020 | |
| GeneOntologyMolecularFunction | protein tyrosine phosphatase activity | 3.41e-03 | 103 | 17 | 2 | GO:0004725 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a tRNA | 6.54e-03 | 144 | 17 | 2 | GO:0140101 | |
| GeneOntologyMolecularFunction | GTPase regulator activity | 8.49e-03 | 507 | 17 | 3 | GO:0030695 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | 8.49e-03 | 507 | 17 | 3 | GO:0060589 | |
| GeneOntologyMolecularFunction | S-adenosylmethionine-dependent methyltransferase activity | 9.22e-03 | 172 | 17 | 2 | GO:0008757 | |
| GeneOntologyBiologicalProcess | neuromuscular synaptic transmission | 2.35e-08 | 36 | 18 | 4 | GO:0007274 | |
| GeneOntologyCellularComponent | manchette | 1.73e-06 | 28 | 18 | 3 | GO:0002177 | |
| MousePheno | ectopic manchette | 1.18e-06 | 19 | 16 | 3 | MP:0009377 | |
| MousePheno | detached sperm flagellum | 1.62e-06 | 21 | 16 | 3 | MP:0008893 | |
| MousePheno | detached acrosome | 1.58e-05 | 44 | 16 | 3 | MP:0009231 | |
| MousePheno | abnormal manchette morphology | 1.70e-05 | 45 | 16 | 3 | MP:0009376 | |
| MousePheno | kinked sperm flagellum | 3.29e-05 | 56 | 16 | 3 | MP:0009237 | |
| MousePheno | abnormal sperm nucleus morphology | 7.59e-05 | 74 | 16 | 3 | MP:0009232 | |
| Domain | SH3 | 3.69e-08 | 216 | 18 | 6 | PS50002 | |
| Domain | SH3_domain | 4.12e-08 | 220 | 18 | 6 | IPR001452 | |
| Domain | SH3_9 | 8.24e-07 | 78 | 18 | 4 | PF14604 | |
| Domain | FN3 | 1.00e-06 | 199 | 18 | 5 | PS50853 | |
| Domain | SH3_2 | 1.22e-06 | 86 | 18 | 4 | IPR011511 | |
| Domain | SH3_2 | 1.22e-06 | 86 | 18 | 4 | PF07653 | |
| Domain | FN3_dom | 1.27e-06 | 209 | 18 | 5 | IPR003961 | |
| Domain | SH3 | 1.50e-06 | 216 | 18 | 5 | SM00326 | |
| Domain | DUF3398 | 1.31e-05 | 6 | 18 | 2 | PF11878 | |
| Domain | DOCK_C/D_N | 1.31e-05 | 6 | 18 | 2 | IPR021816 | |
| Domain | FN3 | 2.56e-05 | 185 | 18 | 4 | SM00060 | |
| Domain | DOCK_C | 4.80e-05 | 11 | 18 | 2 | IPR010703 | |
| Domain | DHR-1_domain | 4.80e-05 | 11 | 18 | 2 | IPR027007 | |
| Domain | DOCK | 4.80e-05 | 11 | 18 | 2 | IPR026791 | |
| Domain | DHR_2 | 4.80e-05 | 11 | 18 | 2 | PS51651 | |
| Domain | DHR_1 | 4.80e-05 | 11 | 18 | 2 | PS51650 | |
| Domain | DOCK-C2 | 4.80e-05 | 11 | 18 | 2 | PF14429 | |
| Domain | DHR-2 | 4.80e-05 | 11 | 18 | 2 | IPR027357 | |
| Domain | DHR-2 | 4.80e-05 | 11 | 18 | 2 | PF06920 | |
| Domain | - | 3.24e-04 | 663 | 18 | 5 | 2.60.40.10 | |
| Domain | Ig-like_fold | 4.32e-04 | 706 | 18 | 5 | IPR013783 | |
| Domain | PTPc | 5.42e-04 | 36 | 18 | 2 | SM00194 | |
| Domain | TYR_PHOSPHATASE_PTP | 6.36e-04 | 39 | 18 | 2 | PS50055 | |
| Domain | PTPase_domain | 7.04e-04 | 41 | 18 | 2 | IPR000242 | |
| Domain | Y_phosphatase | 7.04e-04 | 41 | 18 | 2 | PF00102 | |
| Domain | Tyr_Pase_cat | 1.45e-03 | 59 | 18 | 2 | IPR003595 | |
| Domain | PTPc_motif | 1.45e-03 | 59 | 18 | 2 | SM00404 | |
| Domain | Tyr_Pase_AS | 2.21e-03 | 73 | 18 | 2 | IPR016130 | |
| Domain | TYR_PHOSPHATASE_1 | 3.06e-03 | 86 | 18 | 2 | PS00383 | |
| Domain | TYR_PHOSPHATASE_2 | 3.13e-03 | 87 | 18 | 2 | PS50056 | |
| Domain | TYR_PHOSPHATASE_dom | 3.13e-03 | 87 | 18 | 2 | IPR000387 | |
| Domain | - | 3.49e-03 | 92 | 18 | 2 | 3.90.190.10 | |
| Domain | Prot-tyrosine_phosphatase-like | 4.03e-03 | 99 | 18 | 2 | IPR029021 | |
| Domain | fn3 | 1.04e-02 | 162 | 18 | 2 | PF00041 | |
| Pubmed | Structure and evolution of RIM-BP genes: identification of a novel family member. | 2.51e-13 | 5 | 18 | 4 | 17855024 | |
| Pubmed | RIM-BP3 is a manchette-associated protein essential for spermiogenesis. | 4.65e-10 | 4 | 18 | 3 | 19091768 | |
| Pubmed | Integrative characterization of germ cell-specific genes from mouse spermatocyte UniGene library. | 4.22e-08 | 14 | 18 | 3 | 17662146 | |
| Pubmed | 2.29e-05 | 14 | 18 | 2 | 12432077 | ||
| Pubmed | 3.02e-05 | 16 | 18 | 2 | 8875997 | ||
| Pubmed | SHP-1 dephosphorylates histone H2B to facilitate its ubiquitination during transcription. | 3.02e-05 | 16 | 18 | 2 | 35938192 | |
| Pubmed | 3.82e-05 | 128 | 18 | 3 | 30995482 | ||
| Pubmed | 3.85e-05 | 18 | 18 | 2 | 23534349 | ||
| Pubmed | 4.97e-05 | 407 | 18 | 4 | 12693553 | ||
| Pubmed | CNKSR1 serves as a scaffold to activate an EGFR phosphatase via exclusive interaction with RhoB-GTP. | 5.81e-05 | 22 | 18 | 2 | 34187934 | |
| Pubmed | Large-scale structural analysis of the classical human protein tyrosine phosphatome. | 2.70e-04 | 47 | 18 | 2 | 19167335 | |
| Pubmed | Substrate-trapping techniques in the identification of cellular PTP targets. | 2.93e-04 | 49 | 18 | 2 | 15588985 | |
| Interaction | KLRA1P interactions | 2.65e-05 | 10 | 16 | 2 | int:KLRA1P | |
| Cytoband | 22q11.21 | 1.09e-05 | 111 | 18 | 3 | 22q11.21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr22q11 | 5.56e-04 | 419 | 18 | 3 | chr22q11 | |
| Coexpression | GSE40225_WT_VS_RIP_B7X_DIABETIC_MOUSE_PANCREATIC_CD8_TCELL_UP | 9.08e-06 | 199 | 18 | 4 | M9238 | |
| Coexpression | GSE37301_HEMATOPOIETIC_STEM_CELL_VS_CD4_TCELL_DN | 1.33e-04 | 147 | 18 | 3 | M8882 | |
| Coexpression | GSE14415_NATURAL_TREG_VS_FOXP3_KO_NATURAL_TREG_DN | 1.83e-04 | 164 | 18 | 3 | M2972 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HSERT | 2.17e-04 | 450 | 18 | 4 | M39072 | |
| Coexpression | ZHONG_PFC_C3_MICROGLIA | 2.95e-04 | 488 | 18 | 4 | M39104 | |
| Coexpression | GSE25123_CTRL_VS_IL4_STIM_MACROPHAGE_DN | 3.23e-04 | 199 | 18 | 3 | M7924 | |
| Coexpression | GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY40_UP | 3.28e-04 | 200 | 18 | 3 | M9316 | |
| Coexpression | GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY3_DN | 3.28e-04 | 200 | 18 | 3 | M8486 | |
| Coexpression | GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_LN_DN | 3.28e-04 | 200 | 18 | 3 | M8958 | |
| Coexpression | GSE1460_DP_VS_CD4_THYMOCYTE_UP | 3.28e-04 | 200 | 18 | 3 | M3452 | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 9.00e-07 | 190 | 18 | 4 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Tmem182|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.62e-05 | 124 | 18 | 3 | 690595d710b57b7cff8029a3bb06a8dd7e3c03c1 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.97e-05 | 152 | 18 | 3 | 8ff5a178a8f3550d89a003c0858820aab3773386 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.97e-05 | 152 | 18 | 3 | fed80b467ec9e30c7f98bed6cc4f8c583b715e9e | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.66e-05 | 163 | 18 | 3 | 8d17f44faf0549fe71a9a45f811f50d767275414 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.73e-05 | 164 | 18 | 3 | 08819970174a3eb4eee8e1e675075828665b845e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1_VIP_PCDH20|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.29e-05 | 172 | 18 | 3 | 35e961c88bfe79046533396912cedf00ca81db7b | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.68e-05 | 177 | 18 | 3 | 3a85aa2bf3f2fdbea57d22d68e022cb3f6c2eb65 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L6_LAMP5_C1QL2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.76e-05 | 178 | 18 | 3 | 39889db130216655a34796e7030ffeb372465500 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.16e-05 | 183 | 18 | 3 | 2f0dcc65ad4d90ef946919b4462280fdd20c5ea0 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.16e-05 | 183 | 18 | 3 | 0f02136359787bd78146617990968baa47a65d86 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L6_LAMP5_C1QL2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.33e-05 | 185 | 18 | 3 | 6e7fefdd65d30abaffb26b92b0d04e1630d262ad | |
| ToppCell | Myeloid-B_(Activated_Macrophage)|World / shred on cell class and cell subclass (v4) | 5.42e-05 | 186 | 18 | 3 | 33d731a7883d75e4e7db83b641cdb1e9a39938bf | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.42e-05 | 186 | 18 | 3 | 310d16f4e5cffee3ea6d7635508c513a3b92131e | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 5.59e-05 | 188 | 18 | 3 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.59e-05 | 188 | 18 | 3 | 0501a8aa850bd2e347020abd1cac4d8075738189 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 5.68e-05 | 189 | 18 | 3 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.68e-05 | 189 | 18 | 3 | f0aaf2994d319a39877d2845eaab9f166adead4e | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.77e-05 | 190 | 18 | 3 | 56cc761e50fddfb5366391518b4d8e16589b6b42 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.77e-05 | 190 | 18 | 3 | 25d4b591f75c26e404a34c42f1742d580af6598d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.86e-05 | 191 | 18 | 3 | fa50a3c7ff86e1ee07100da1ace0b0fa1b0ab26b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.86e-05 | 191 | 18 | 3 | 7b386512284dfaa0e95358b28ee82632ee965e64 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.96e-05 | 192 | 18 | 3 | f6ec683b2133b3095a1fcc06ca8605cf38f774b5 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.96e-05 | 192 | 18 | 3 | 690b3d17c481159bc96b8bc7f6a66b51343ee858 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.14e-05 | 194 | 18 | 3 | 52aebb0b563e2c2058e7f0554ae870e47692b163 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.14e-05 | 194 | 18 | 3 | bd06e2b8d8c06cddf2e4f58849b86e09013acae1 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.14e-05 | 194 | 18 | 3 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.24e-05 | 195 | 18 | 3 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.24e-05 | 195 | 18 | 3 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.43e-05 | 197 | 18 | 3 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.43e-05 | 197 | 18 | 3 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.43e-05 | 197 | 18 | 3 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | PCW_10-12|World / Celltypes from embryonic and fetal-stage human lung | 6.43e-05 | 197 | 18 | 3 | 47fd8b0d596c5db1a722473c8efbb17a6bbe7538 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.72e-05 | 200 | 18 | 3 | d416a7be1a4e6232fb58a9687774da24821f1fdd | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.72e-05 | 200 | 18 | 3 | 862db57d043bdf3cb059fbfc8b29bc1eafdf64ec | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR--L1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.72e-05 | 200 | 18 | 3 | a91345f268f13170c27309333603eb82400c9947 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Mucinous_and_Papillary_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 8.06e-04 | 105 | 18 | 2 | cfd271e2cd004d6815bcc3ce7cad86fe62b5299b | |
| ToppCell | Control-Lymphoid_T/NK-NK_activated|Control / Disease group, lineage and cell class | 1.03e-03 | 119 | 18 | 2 | a258d91ac90d4174b6f203d7f96ba6e57c6003e7 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Pax6|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.07e-03 | 121 | 18 | 2 | 7f2057367777c6c92f596054cbc5fe567d079fbc | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Tmem182|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.23e-03 | 130 | 18 | 2 | 8bd038b0423960ffdc6c8b128c46a55386f9c58c | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Pax6|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.23e-03 | 130 | 18 | 2 | 60e28d452d0e2af768459ba8dbe998117c94a251 | |
| ToppCell | PND01-03-samps-Myeloid-Macrophage-macrophage_-_intermediate_-_unactivated|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.27e-03 | 132 | 18 | 2 | 617644597726e881cd343e57f6edb5a98473b421 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_smooth_muscle-like|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.27e-03 | 132 | 18 | 2 | 9633653dba1edee47d915212fb6e68426da49de5 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Tacstd2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.48e-03 | 143 | 18 | 2 | 24fd24846fbef049af669a57d42fcc18928d2b27 | |
| ToppCell | Control-Lymphocytic_NKT-iNKT/MAIT-T-cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.59e-03 | 148 | 18 | 2 | 003e10bf477984248211b99d75daa8f7dcdb12c8 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.59e-03 | 148 | 18 | 2 | 5e738522d4ad35e08bc4ff8c41b7bea38ec6ef95 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.59e-03 | 148 | 18 | 2 | afebb64365c94b9476494bffe7c364677f19c8cf | |
| ToppCell | Thalamus-Neuronal-Inhibitory|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.59e-03 | 148 | 18 | 2 | 5f82e5ecacfd223020b8ee975c17d68c1fe6db38 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Rxfp1_Prdm8|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.65e-03 | 151 | 18 | 2 | 090b067873740c282865e2d02cf47d5cb3dd7607 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.65e-03 | 151 | 18 | 2 | 75c068b3e3aae5f9ba64d5fa5d1e2105a60e4293 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-03 | 151 | 18 | 2 | c743dc8758416a4f562d60c8fd2df7e659ab6951 | |
| ToppCell | Children_(3_yrs)-Immune-mast_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.70e-03 | 153 | 18 | 2 | d3fb83ca984c7583b1e51c364be6c7c17f67b048 | |
| ToppCell | Control-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.74e-03 | 155 | 18 | 2 | 0a78d1cab2bdba2dc8a74cdf35b5a0192370c4b5 | |
| ToppCell | PND07-28-samps|World / Age Group, Lineage, Cell class and subclass | 1.78e-03 | 157 | 18 | 2 | a2005768a6d268879e3fd6dbd8cf674dc98be587 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.78e-03 | 157 | 18 | 2 | 516903469756c5fabfdf56d7bd59b3bdd7b44e39 | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Biphasic-6|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 1.83e-03 | 159 | 18 | 2 | 85501c636cd04f15ba1be24df1ba7ac909633ce8 | |
| ToppCell | Severe-B_naive-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.83e-03 | 159 | 18 | 2 | 2881b054bbeb479221ee3c38bbd9b0815b123579 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.83e-03 | 159 | 18 | 2 | 0c2437da5443fc3aff66f8ef311f02aa434a1fb0 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lsp1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.83e-03 | 159 | 18 | 2 | 0dccc4275b9b4f8554dd556da7218e130bff8fd1 | |
| ToppCell | IPF-Epithelial-PNEC|IPF / Disease state, Lineage and Cell class | 1.83e-03 | 159 | 18 | 2 | adec82df944fe8699a69ca52534353bef100f2f9 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.85e-03 | 160 | 18 | 2 | 0293b244c063a62819690bf22bbc2681f8d15252 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.85e-03 | 160 | 18 | 2 | 3eaae86fa08f7651021316f8e5811bf48055591e | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.88e-03 | 161 | 18 | 2 | 9703b7e67d9fadb6129cad166bd01be915042e44 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.90e-03 | 162 | 18 | 2 | 810881210e015c788814e4fe8d7a24c929cf2621 | |
| ToppCell | E18.5-samps-Myeloid-Macrophage-macrophage_-_intermediate_-_unactivated|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.90e-03 | 162 | 18 | 2 | 60d3fe1f5cec4285b8774ff078ebcc6bfaec26ed | |
| ToppCell | E18.5-samps-Myeloid|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.90e-03 | 162 | 18 | 2 | 18e4a807e25f754a69e9eaaddfde40f8de9b8512 | |
| ToppCell | IPF-Epithelial-PNEC|Epithelial / Disease state, Lineage and Cell class | 1.90e-03 | 162 | 18 | 2 | 865d0e215d54fb1412f00cf0649c71c2f1878e57 | |
| ToppCell | E18.5-samps-Myeloid-Macrophage|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.90e-03 | 162 | 18 | 2 | 0970e4eda60e3f015335e2726e6d565fb2f43372 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 1.90e-03 | 162 | 18 | 2 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lsp1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.92e-03 | 163 | 18 | 2 | bba830a302919c8b33f914a8839877fc21dd28a0 | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.92e-03 | 163 | 18 | 2 | f558ad9569e5137e62a601ba4f073e69ed8f8650 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.94e-03 | 164 | 18 | 2 | be49af6335f2505065cde2cb9800e4a5516811b1 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.94e-03 | 164 | 18 | 2 | 6a113191ea91d103d21c5f056b1950217688ea26 | |
| ToppCell | PND01-03-samps-Myeloid-Macrophage|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.94e-03 | 164 | 18 | 2 | 49733a9d3d95f05056b5b01916060ff20a8de3cf | |
| ToppCell | Multiple_Sclerosis-Other-HSPC|Multiple_Sclerosis / Disease, Lineage and Cell Type | 1.94e-03 | 164 | 18 | 2 | 6af5529507d695b347adee4be5ead70f56c9cf55 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.97e-03 | 165 | 18 | 2 | 1dcd6b8aa192baeaa1f7bb334843edab6049b96f | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.97e-03 | 165 | 18 | 2 | 4b4e75ad0eb0a6b00c30a000ec6267e23ba2e496 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibrocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-03 | 165 | 18 | 2 | 8a52f2dbcbd2bc1662b5e3fac381463fdcc3bf14 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.97e-03 | 165 | 18 | 2 | a74751e0ec857aa974bec04ccc747c004a8f6e01 | |
| ToppCell | CV-Mild-3|Mild / Virus stimulation, Condition and Cluster | 1.99e-03 | 166 | 18 | 2 | 5599f90fc0e15a3670b03187085eba91228390a2 | |
| ToppCell | PND01-03-samps-Myeloid|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.99e-03 | 166 | 18 | 2 | 99dc8a186ec12d3563e81fa4618a814740332c73 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.02e-03 | 167 | 18 | 2 | 5accd0bc7c95089feb2c09376d12cd8bd3773775 | |
| ToppCell | PND07-28-samps-Myeloid|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.04e-03 | 168 | 18 | 2 | 87512f9e5e95333e7ffc6efa1e93bab2ba9154c6 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.06e-03 | 169 | 18 | 2 | 305cedbd97059029d7d2a248a8a4b6cfe281aa54 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.06e-03 | 169 | 18 | 2 | b6b5bb6408c1305a00719e1b88a5e1202081faf3 | |
| ToppCell | droplet-Fat-Gat-18m-Lymphocytic-B_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-03 | 170 | 18 | 2 | 5185187ecf26b4c9eaa0c01ad52697ab8d075cc7 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.09e-03 | 170 | 18 | 2 | 138235227fc4c3d660c3a06e8e5167bf64f076b3 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.09e-03 | 170 | 18 | 2 | 6686d1797988216c0d9417f21a2537369abce410 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-03 | 170 | 18 | 2 | 71c52fadecc6b4bfe98692b266adaa1406f6d56d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.11e-03 | 171 | 18 | 2 | b6502a81df4f25660f3ae4b7443a1d999df2d32b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic-Mast_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.11e-03 | 171 | 18 | 2 | ac37c80c832504986c7a201d84f4b6aff5e5f323 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-neuro-epithelial-EECs|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.11e-03 | 171 | 18 | 2 | dd37e1693a5cfc42e40992d504f92048a8038b52 | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-03 | 171 | 18 | 2 | 7c4362eeacbe52d7f4fdf93c841d7b59526328c1 | |
| ToppCell | Control-B_naive-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.11e-03 | 171 | 18 | 2 | d18855b24aadea38fd1e4592f945cf15b85e05f1 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Myeloid|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-03 | 172 | 18 | 2 | 0c0ae2da3cba6022403434567800f16e61a34a2b | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-03 | 172 | 18 | 2 | 3a37569a5902f3c65ff8d3912421309a8c82ee9b | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.14e-03 | 172 | 18 | 2 | 172e3c78f8e97988a4fd8624514e731282ddc16d | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.14e-03 | 172 | 18 | 2 | 2214cc37d7c21b868768d3f74ca4631d339d37b3 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Myeloid-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-03 | 172 | 18 | 2 | d80c207f3489be2da2f40f47a7835cb73c949c3e | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Mast_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-03 | 172 | 18 | 2 | cc9d9dae290f11f8c348c78228af4e49469dc93b | |
| Computational | Genes in the cancer module 120. | 8.84e-04 | 71 | 7 | 2 | MODULE_120 | |
| Drug | Nadolol [42200-33-9]; Down 200; 13uM; MCF7; HT_HG-U133A | 9.30e-06 | 198 | 16 | 4 | 4139_DN | |
| Drug | Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Up 200; 6.4uM; MCF7; HT_HG-U133A | 9.30e-06 | 198 | 16 | 4 | 2259_UP | |
| Drug | rapamycin, Streptomyces hygroscepicus; Down 200; 0.1uM; MCF7; HT_HG-U133A | 9.68e-06 | 200 | 16 | 4 | 5927_DN | |
| Drug | CAS 520-26-3 | 1.73e-04 | 28 | 16 | 2 | CID000003594 | |
| Drug | Hydrocotarnine hydrobromide [5985-00-2]; Down 200; 13.2uM; HL60; HG-U133A | 2.69e-04 | 184 | 16 | 3 | 1772_DN | |
| Drug | 5707885; Up 200; 50uM; PC3; HT_HG-U133A | 2.78e-04 | 186 | 16 | 3 | 6438_UP | |
| Drug | Furosemide [54-31-9]; Up 200; 12uM; HL60; HG-U133A | 3.05e-04 | 192 | 16 | 3 | 1580_UP | |
| Drug | Clorgyline hydrochloride [17780-75-5]; Up 200; 13uM; MCF7; HT_HG-U133A | 3.10e-04 | 193 | 16 | 3 | 5005_UP | |
| Drug | Estrone [53-16-7]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 3.19e-04 | 195 | 16 | 3 | 6448_UP | |
| Drug | Flavoxate hydrochloride [3717-88-2]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 3.19e-04 | 195 | 16 | 3 | 5427_DN | |
| Drug | Molindone hydrochloride [15622-65-8]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 3.24e-04 | 196 | 16 | 3 | 7337_UP | |
| Drug | Acetopromazine maleate salt [3598-37-6]; Up 200; 9uM; MCF7; HT_HG-U133A | 3.24e-04 | 196 | 16 | 3 | 6832_UP | |
| Drug | Etodolac [41340-25-4]; Up 200; 14uM; MCF7; HT_HG-U133A | 3.24e-04 | 196 | 16 | 3 | 2254_UP | |
| Drug | PF-01378883-00 [351320-41-7]; Up 200; 10uM; MCF7; HT_HG-U133A | 3.24e-04 | 196 | 16 | 3 | 6363_UP | |
| Drug | Piroxicam [36322-90-4]; Up 200; 12uM; MCF7; HT_HG-U133A | 3.29e-04 | 197 | 16 | 3 | 2252_UP | |
| Drug | Flufenamic acid [530-78-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 3.29e-04 | 197 | 16 | 3 | 2267_UP | |
| Drug | PF-00875133-00 [351322-64-0]; Down 200; 10uM; MCF7; HT_HG-U133A | 3.29e-04 | 197 | 16 | 3 | 5923_DN | |
| Drug | Chenodiol [474-25-9]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 3.29e-04 | 197 | 16 | 3 | 6012_DN | |
| Drug | 3-nitropropionic acid; Down 200; 10uM; PC3; HT_HG-U133A | 3.29e-04 | 197 | 16 | 3 | 6372_DN | |
| Drug | Esculin Hydrate [531-75-9]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 3.29e-04 | 197 | 16 | 3 | 5411_UP | |
| Drug | Sulfamerazine [127-79-7]; Up 200; 15.2uM; MCF7; HT_HG-U133A | 3.29e-04 | 197 | 16 | 3 | 3616_UP | |
| Drug | Tropicamide [1508-75-4]; Down 200; 14uM; MCF7; HT_HG-U133A | 3.29e-04 | 197 | 16 | 3 | 4744_DN | |
| Drug | Bromopride [4093-35-0]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 3.34e-04 | 198 | 16 | 3 | 6037_UP | |
| Drug | Doxazosin mesylate [77883-43-3]; Down 200; 7.4uM; HL60; HT_HG-U133A | 3.34e-04 | 198 | 16 | 3 | 3024_DN | |
| Drug | Lansoprazole [103577-45-3]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 3.34e-04 | 198 | 16 | 3 | 6009_DN | |
| Drug | Isocarboxazid [59-63-2]; Up 200; 17.2uM; MCF7; HT_HG-U133A | 3.34e-04 | 198 | 16 | 3 | 4706_UP | |
| Drug | celecoxib; Up 200; 10uM; PC3; HG-U133A | 3.34e-04 | 198 | 16 | 3 | 482_UP | |
| Drug | Bisoprolol fumarate; Up 200; 9uM; PC3; HT_HG-U133A | 3.34e-04 | 198 | 16 | 3 | 6748_UP | |
| Drug | Streptomycin sulfate [3810-74-0]; Down 200; 2.8uM; PC3; HT_HG-U133A | 3.34e-04 | 198 | 16 | 3 | 5837_DN | |
| Drug | Spironolactone [52-01-7]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 3.34e-04 | 198 | 16 | 3 | 2226_UP | |
| Drug | pioglitazone HCl; Down 200; 10uM; MCF7; HT_HG-U133A | 3.39e-04 | 199 | 16 | 3 | 5925_DN | |
| Drug | Etofylline [519-37-9]; Down 200; 17.8uM; PC3; HT_HG-U133A | 3.39e-04 | 199 | 16 | 3 | 5048_DN | |
| Drug | SB 202190; Up 200; 1uM; PC3; HT_HG-U133A | 3.39e-04 | 199 | 16 | 3 | 7058_UP | |
| Drug | Metformin hydrochloride [1115-70-4]; Down 200; 24.2uM; PC3; HT_HG-U133A | 3.39e-04 | 199 | 16 | 3 | 5068_DN | |
| Drug | Rilmenidine hemifumarate [54187-04-1]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 3.44e-04 | 200 | 16 | 3 | 5532_UP | |
| Drug | Eucatropine hydrochloride [536-93-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 3.44e-04 | 200 | 16 | 3 | 3935_UP | |
| Drug | Sulfinpyrazone [57-96-5]; Down 200; 9.8uM; HL60; HG-U133A | 3.44e-04 | 200 | 16 | 3 | 1574_DN | |
| Disease | free cholesterol to total lipids in large LDL percentage | 5.54e-04 | 74 | 14 | 2 | EFO_0022280 | |
| Disease | coronary artery calcification | 1.13e-03 | 450 | 14 | 3 | EFO_0004723 | |
| Disease | serum IgG glycosylation measurement | 1.74e-03 | 523 | 14 | 3 | EFO_0005193 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 2.07e-03 | 144 | 14 | 2 | EFO_0004611, EFO_0020943 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 2.24e-03 | 150 | 14 | 2 | EFO_0004611, EFO_0020947 | |
| Disease | HMG CoA reductase inhibitor use measurement | 3.53e-03 | 189 | 14 | 2 | EFO_0009932 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 3.94e-03 | 200 | 14 | 2 | EFO_0004611, EFO_0020945 | |
| Disease | colorectal health | 3.98e-03 | 201 | 14 | 2 | EFO_0008460 | |
| Disease | eye colour measurement | 4.66e-03 | 218 | 14 | 2 | EFO_0009764 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 4.83e-03 | 222 | 14 | 2 | EFO_0008317, EFO_0020943 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 4.92e-03 | 224 | 14 | 2 | EFO_0004530, EFO_0008317 | |
| Disease | platelet component distribution width | 4.92e-03 | 755 | 14 | 3 | EFO_0007984 | |
| Disease | heart rate | 4.96e-03 | 225 | 14 | 2 | EFO_0004326 | |
| Disease | phospholipids:total lipids ratio | 5.05e-03 | 227 | 14 | 2 | EFO_0020946 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 5.58e-03 | 239 | 14 | 2 | EFO_0008317, EFO_0020945 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 5.76e-03 | 243 | 14 | 2 | EFO_0004612, EFO_0020944 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | 5.80e-03 | 801 | 14 | 3 | EFO_0003888, EFO_0007052, MONDO_0002491 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 6.76e-03 | 264 | 14 | 2 | EFO_0008317, EFO_0020944 | |
| Disease | complex trait | 7.11e-03 | 271 | 14 | 2 | EFO_0010578 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 7.37e-03 | 276 | 14 | 2 | EFO_0004612, EFO_0020943 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YIFGDMDEDGFYEGE | 866 | A6NNM3 | |
| YIFGDMDEDGFYEGE | 866 | A6NJZ7 | |
| FKDGSYYEGAFVDGE | 56 | Q5T089 | |
| FTDFKLDGTGYGDYV | 301 | Q9Y561 | |
| EEISCYYGDGFFGEN | 301 | Q4FZB7 | |
| YYGDGFFGENNEFCE | 306 | Q4FZB7 | |
| EDSFDFIGGFDSYGY | 176 | Q5VXU1 | |
| FDRDGDGYIDYYEFV | 3216 | O94854 | |
| GYEENYFFIFREGDG | 306 | Q8N7H5 | |
| AFYGQGFFEEEEGKE | 1881 | Q96BY6 | |
| GFYGTKFGDLDEQEF | 1846 | Q96N67 | |
| EGYGFKEEYESFFEG | 896 | P28827 | |
| GEFYYGEFSDGSNEA | 221 | Q99574 | |
| YVYGDMDEDGFYEGE | 201 | O15034 | |
| ITVFGEIDEDGFYYG | 986 | O15034 | |
| GFDGTLFDYFNGYED | 161 | Q96Q11 | |
| YIFGDMDEDGFYEGE | 866 | Q9UFD9 | |
| YYDEFGFRVYKEEGD | 41 | Q96HU1 | |
| NSGDFYDLYGGEKFA | 56 | P29350 | |
| FANISKEGEEEYGFY | 226 | Q9P272 |